TESSY ALOZIE: Open Payments
NPI 1700401510 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,698 in 63 payments from 12 companies in 2025. Trend: 2023 $1,460 · 2024 $2,454 · 2025 $1,698
Food & beverage: $1,698
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $647 |
| Alkermes, Inc. | 8 | $174 |
| E.R. Squibb & Sons, L.L.C. | 3 | $171 |
| Vanda Pharmaceuticals Inc. | 5 | $161 |
| Neurocrine BioSciences, Inc. | 4 | $159 |
| Supernus Pharmaceuticals, Inc. | 7 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| ABBVIE INC. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Lundbeck LLC | 1 | $20 |
Products named: REXULTI, COBENFY, FANAPT, INGREZZA, ABILIFY MAINTENA, LYBALVI, Qelbree, CAPLYTA.
Industry payments across PA — which companies pay providers there.
